Strengthening the HLHS Heart With Regenerative Medicine

Timothy J. Nelson, M.D., Ph.D., director of the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Joseph A. Dearani, M.D., Cardiovascular Surgery division chair, and pediatric cardiologist Muhammad (Yasir) Y. Qureshi, M.B.B.S., discuss how regenerative medicine — the ability to bioengineer and make new heart muscle and apply it to patients with weak hearts — is changing the future for children with hypoplastic left heart syndrome.

Learn more about clinical trials for patients with hypoplastic left heart syndrome at Mayo Clinic.


Created by

Mayo Clinic